Navigation Links
Protein Sciences Prepared to Combat the Latest Potential Pandemic Flu Virus
Date:5/2/2013

nth period than is required by our contract with the Biomedical Advanced Research and Development Authority (BARDA)."

About Us

Protein Sciences Corporation is a vaccine development and protein production company that is dedicated to saving lives and improving health through the creation of innovative vaccines and biopharmaceu­ticals.  

On January 16, 2013, the U.S. FDA approved Flublok, the world's first recombinant protein-based vaccine for the prevention of seasonal influenza disease, for use in adults 18-49 years old. 

Flublok and its sister vaccine, Panblok®, that is designed to protect against pandemic influenza, have been developed in partnership with BARDA through Contract No. HHS0100200900106C. 

Learn more at www.proteinsciences.com and www.flublok.com.


'/>"/>
SOURCE Protein Sciences Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
2. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
3. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
4. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
5. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
6. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
7. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
8. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
9. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
10. ProteinSimple Charges Ahead with the Simple Western
11. Advantages of Pressure BioSciences PCT Platform Highlighted at a Recent International Scientific Conference Focused on the Role of Proteins in the Cause, Prevention, and Treatment of Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mike Rowe , spokesperson and reality television ... Pharmacy,s 2015 ThoughtSpot conference and tradeshow, which ... Las Vegas, Nev. Best known ... and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent a decade ... – people whose hard work, sacrifice and value aren,t always ...
(Date:7/28/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today its results for the ... Pat Mackin, Chairman, President and Chief Executive ... on our growth strategy with solid progress on several ... plans to transition to a direct sales model in ...
(Date:7/28/2015)... YORK , July 28, 2015 ... late-stage pharmaceutical company focused on the development and ... that new Locilex® microbiology data will be presented ... of Antimicrobial Agents and Chemotherapy and International Society ... (ICAAC/ICC 2015) scientific meeting in San ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... A study comparing,the formulations of isosorbide dinitrate (ISDN) ... II, and BiDil, the proprietary,fixed dose combination, used ... no bioequivalence. Non-bioequivalence,in the formulations used may explain ... results in decreasing mortality. Using,identical amounts of active ...
... 26, 2007 /PRNewswire/ -- DiObex,Inc., a privately- ... therapeutics to treat metabolic diseases, today,announced positive ... novel Cortisol,Synthesis Inhibitor. , In a recently ... 2 diabetes were,treated for two weeks to ...
Cached Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
(Date:7/28/2015)... Nashville, Tenn. (PRWEB) , ... July 28, 2015 ... ... has added the SmileCareClub Invisible Aligner System to its online product ... , By using a teledentistry model and cloud-based technology, SmileCareClub allows patients to ...
(Date:7/28/2015)... Wayne, PA (PRWEB) , ... July 28, 2015 ... ... that its Board of Directors has authorized the Company, from time to time ... with an aggregate value of up to $25 million. Repurchases will be made ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... services to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... evidence based. It provides physicians who are anticipating making a subspecialty referral ...
(Date:7/28/2015)... ... 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta Center ... Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for ... in the metro area as one of the most respected doctors in Reproductive Endocrinology. ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published ... Fibromyalgia, Study Says " sheds light on a possible new treatment option for people ... months of regular HBOT sessions, at least five per week, patients experienced a significant ...
Breaking Medicine News(10 mins):Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3
... - Region,s Fastest Growing Private Company* Delivers Quality, ... in Patients, Needs -, GLENDALE, Calif., Nov. ... (2005 through 2007) earned it the status as ... the region,s top business media,Lakeside Systems, Inc. (Lakeside) ...
... Increases Fund Size for Venture Team by 30%, ... Ventures (, http://www.morgenthaler.com/ventures ), a leading venture ... today that it has exceeded its,fundraising goal and ... $400,million. This brings the firm,s total capital under ...
... PLC Systems Inc.,(Pink Sheets: PLCSF), a company ... today stated that, following the,delisting of its common ... Stock Exchange) on Monday, November 10, 2008, the ... its common stock listing to the,OTCBB. Until that ...
... articles that stress African-American health disparities, like higher ... black patients from being screened for cancer, according ... are more likely to be tested for cancer ... among African-American cancer patients. , While the medical ...
... International Conference on Wireless ... Identification in Milan, HATBORO, Pa., ... of enterprise mobility and advanced,wireless asset tracking solutions for the healthcare ... on the predictive value of identification technology at the ID,WORLD International ...
... Closed in 2008, According to New Report,from HealthLeaders-InterStudy, ... provider of managed care market intelligence, reports that ... better than health systems,in other parts of the ... to the new Southern New Jersey Market Overview, ...
Cached Medicine News:Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 2Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 3Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 4Health News:Morgenthaler Closes Ninth Fund at $400 Million 2Health News:Morgenthaler Closes Ninth Fund at $400 Million 3Health News:Morgenthaler Closes Ninth Fund at $400 Million 4Health News:PLC Systems Updates Common Stock Listing Status 2Health News:Messages of hope work better in motivating black patients to seek early screening for cancer 2Health News:InfoLogix CEO to Address Hidden Value of ID Technology at International Conference 2Health News:InfoLogix CEO to Address Hidden Value of ID Technology at International Conference 3Health News:Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions 2Health News:Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions 3
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... system continues the "Consensus Concept" approach to ... diversified experience of a Scientific Advisory Board. ... that incorporates state-of-the-art features. Consensus Knee implants ... implant stability and allow near normal kinematics. ...
Medicine Products: